“Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market” report has been added to DelveInsight
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Overview
Palmar-plantar erythrodysesthesia (PPE), also called a hand-foot syndrome, is a relatively common dermatologic toxic reaction associated with cytotoxic chemotherapy that can limit the use of such drugs.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market
DelveInsight’s “Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome, historical and forecasted epidemiology as well as the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Report
The Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market report provides current treatment practices, emerging drugs, Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market share of the individual therapies, current and forecasted Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Request free sample copy- https://www.delveinsight.com/sample-request/hand-foot-syndrome-market
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Regions Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Symptoms
- Numbness
- Tingling, Burning, Or Itching Sensation
- Redness (Resembling A Sunburn)
- Swelling
- Discomfort
- Tenderness
- Rash
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Diagnosis
Painful red swelling of the feet and hands in a patient receiving chemotherapy suggests the diagnosis. A high degree of suspicion is the key to diagnosis in patients receiving chemotherapeutic agents. The problem may also occur in patients with bone marrow transplants, as the clinical and histologic features may mimic cutaneous manifestations of graft-versus-host disease.
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Treatment
HFS, although not a life-threatening reaction, it certainly affects QoL and is often a proper dose-risking side effect. With the extension of the use of capecitabine in the adjuvant treatment of colorectal cancer, the incidence of HFS is likely to increase. The prevention and treatment of these reactions are essential to improve the QoL of cancer patients and to avoid unnecessary dose modifications that may affect treatment outcome. It is now clear that even mild cases may be associated with considerable discomfort and dramatic impact on the QoL. Till date, there is a gap in literature on randomized blind studies on therapeutic procedures for HFS or HFSR.
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Size
The market size shall grow during the forecast period owing to the increased Research and Development activities and increased patient pool. Drugs in the clinical trials are expected to propel the growth of the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome drugs market in the upcoming years.
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Drug Chapters
Drug chapter segment of the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome report encloses the detailed analysis of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Outlook
The Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market or expected to get launched in the market during the study period 2017-2030. The analysis covers Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.
Table of Content
1. Key Insights
2. Executive Summary of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome
3. Competitive Intelligence Analysis for Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome
4. Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Market Overview at a Glance
5. Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Disease Background and Overview
6. Patient Journey
7. Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment
11. Marketed Products
12. Emerging Therapies
13. Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market: Report Scope
• The report covers the descriptive overview of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market.
Why should you buy this report?
• The report will help in developing business strategies by understanding trends shaping and driving the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market
• To understand the future market competition in the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market
• To understand the future market competition in the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market.
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/